featured
news articles

Total number of categories

Total number of articles

Featured

Findings from an international genomics consortium almost double the number of associated genetic loci and variants for AMD

Research conducted by the International AMD Genomics Consortium (IAMDGC) has recently reported an almost doubling in the number of genetic risk loci associated with age-related macular degeneration (AMD). In a significant publication in the journal Nature Genetics, the research group has reported on an analysis of >12 million gene variants, “including 163,714 directly genotyped, mostly […]

Read full story
Market/Novel Tech

Graybug Vision Inc. raises $44.5M for neovascular AMD therapy that reduces dosing to once every 6 months

California-based company Graybug Vision Inc. has announced the closing of a $44.5 million Series B financing to support commercialisation of a novel AMD therapeutic which may reduce dosing to as little as two injections per annum. The company is developing its lead drug for wet AMD, GB-102, and will employ the investment to complete a […]

Read full story
Featured

Cohort series among DME patients indicates conversion to aflibercept after prior anti-VEGF treatment may confer benefit for patients

Clinical research conducted by ophthalmologists from the Retina Service of Wills Eye Hospital, Mid Atlantic Retina and the Department of Ophthalmology, University of Pennsylvania has shown significant anatomic improvement in patients with persistent DME when switched from bevacizumab / ranibuzumab to aflibercept. The retrospective interventional non-comparative case series study was performed to evaluate outcomes of […]

Read full story
Research

Gene therapy using angiotensin-converting enzyme 2 reverses diabetic retinopathy in animal model

Research, conducted at the University of Florida College of Medicine, has shown that adeno-associated viral (AAV) delivery of angiotensin-converting enzyme (ACE)-2 is capable of preventing and partially reversing diabetic retinopathy in models of type-1 diabetes. The finding provides encouraging data for the development of therapeutic opportunities to tackle a global public health challenge expected to […]

Read full story
Introduction

May 17th, 2016: “EURETINA-Brief”© Issue No. 133

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the May 17th, 2016 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]

Read full story
Introduction

January 18th, 2016: “EURETINA-Brief”© Issue No. 125

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the January 18th, 2016 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]

Read full story

Latest News

Book Review